贾第虫病:综述。

IF 4.2 Q3 Pharmacology, Toxicology and Pharmaceutics
Alexander K C Leung, Amy A M Leung, Alex H C Wong, Consolato M Sergi, Joseph K M Kam
{"title":"贾第虫病:综述。","authors":"Alexander K C Leung,&nbsp;Amy A M Leung,&nbsp;Alex H C Wong,&nbsp;Consolato M Sergi,&nbsp;Joseph K M Kam","doi":"10.2174/1872213X13666190618124901","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Giardiasis is an important cause of waterborne and foodborne diarrhea, daycare center outbreaks, and traveler's diarrhea.</p><p><strong>Objective: </strong>The study aimed to provide an update on the evaluation, diagnosis, and treatment of giardiasis.</p><p><strong>Methods: </strong>A PubMed search was completed in Clinical Queries using the key terms \"giardiasis\", \"Giardia lamblia\", \"Giardia duodenalis\" and \"Giardia intestinalis\". The search strategy included metaanalyses, randomized controlled trials, clinical trials, observational studies, and reviews. The search was restricted to the English literature. Patents were searched using the key term \"giardiasis\" from www.freepatentsonline.com.</p><p><strong>Results: </strong>Giardiasis is caused by the protozoan parasite Giardia lamblia. The parasite is transmitted by the fecal-oral route, frequently through ingestion of contaminated water and food or person-to person transmission. Risk factors for infection include children in day-care settings, child-care workers, institutionalized individuals, travelers in endemic areas, ingestion of contaminated or recreational water, immunodeficiency, cystic fibrosis, and oral-anal sex. Approximately 50 to 75% of infected children are asymptomatic. Other children present acute or chronic diarrhea. Direct fluorescent antibody tests that detect intact organisms, enzyme immunoassays that detect soluble antigens, and multiplex real-time polymerase chain reaction assays that detect specific genes of the parasite in stool samples have improved sensitivity and specificity compared with microscopic examination of stool specimens for the detection of Giardia trophozoites or cysts. Drugs used in the treatment of symptomatic giardiasis are reviewed in this study. Moreover, recent patents related to the management of giardiasis are also discussed.</p><p><strong>Conclusion: </strong>Metronidazole, tinidazole, and nitazoxanide are drugs of choice. Resistance to common antigiardial drugs has increased in recent years, therefore, the search for new molecular targets for antigiardial drugs is urgently needed. In general, treatment of asymptomatic carriers is not recommended. Purification of water supply is an important preventive measure.</p>","PeriodicalId":20960,"journal":{"name":"Recent patents on inflammation & allergy drug discovery","volume":"13 2","pages":"134-143"},"PeriodicalIF":4.2000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1872213X13666190618124901","citationCount":"41","resultStr":"{\"title\":\"Giardiasis: An Overview.\",\"authors\":\"Alexander K C Leung,&nbsp;Amy A M Leung,&nbsp;Alex H C Wong,&nbsp;Consolato M Sergi,&nbsp;Joseph K M Kam\",\"doi\":\"10.2174/1872213X13666190618124901\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Giardiasis is an important cause of waterborne and foodborne diarrhea, daycare center outbreaks, and traveler's diarrhea.</p><p><strong>Objective: </strong>The study aimed to provide an update on the evaluation, diagnosis, and treatment of giardiasis.</p><p><strong>Methods: </strong>A PubMed search was completed in Clinical Queries using the key terms \\\"giardiasis\\\", \\\"Giardia lamblia\\\", \\\"Giardia duodenalis\\\" and \\\"Giardia intestinalis\\\". The search strategy included metaanalyses, randomized controlled trials, clinical trials, observational studies, and reviews. The search was restricted to the English literature. Patents were searched using the key term \\\"giardiasis\\\" from www.freepatentsonline.com.</p><p><strong>Results: </strong>Giardiasis is caused by the protozoan parasite Giardia lamblia. The parasite is transmitted by the fecal-oral route, frequently through ingestion of contaminated water and food or person-to person transmission. Risk factors for infection include children in day-care settings, child-care workers, institutionalized individuals, travelers in endemic areas, ingestion of contaminated or recreational water, immunodeficiency, cystic fibrosis, and oral-anal sex. Approximately 50 to 75% of infected children are asymptomatic. Other children present acute or chronic diarrhea. Direct fluorescent antibody tests that detect intact organisms, enzyme immunoassays that detect soluble antigens, and multiplex real-time polymerase chain reaction assays that detect specific genes of the parasite in stool samples have improved sensitivity and specificity compared with microscopic examination of stool specimens for the detection of Giardia trophozoites or cysts. Drugs used in the treatment of symptomatic giardiasis are reviewed in this study. Moreover, recent patents related to the management of giardiasis are also discussed.</p><p><strong>Conclusion: </strong>Metronidazole, tinidazole, and nitazoxanide are drugs of choice. Resistance to common antigiardial drugs has increased in recent years, therefore, the search for new molecular targets for antigiardial drugs is urgently needed. In general, treatment of asymptomatic carriers is not recommended. Purification of water supply is an important preventive measure.</p>\",\"PeriodicalId\":20960,\"journal\":{\"name\":\"Recent patents on inflammation & allergy drug discovery\",\"volume\":\"13 2\",\"pages\":\"134-143\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2174/1872213X13666190618124901\",\"citationCount\":\"41\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recent patents on inflammation & allergy drug discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1872213X13666190618124901\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on inflammation & allergy drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1872213X13666190618124901","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 41

摘要

背景:贾第虫病是水媒和食源性腹泻、日托中心暴发和旅行者腹泻的重要原因。目的:本研究旨在为贾第虫病的评估、诊断和治疗提供最新信息。方法:以“贾第鞭毛虫病”、“蓝氏贾第鞭毛虫”、“十二指肠贾第鞭毛虫”和“肠贾第鞭毛虫”为关键词,在PubMed的“临床查询”中进行检索。检索策略包括荟萃分析、随机对照试验、临床试验、观察性研究和综述。搜索仅限于英国文献。使用关键词“贾第虫病”从www.freepatentsonline.com.Results上搜索专利:贾第虫病是由原生动物寄生虫贾第虫引起的。寄生虫通过粪口途径传播,通常通过摄入受污染的水和食物或人际传播。感染的危险因素包括日托环境中的儿童、儿童保育工作者、被收容的个人、流行地区的旅行者、饮用受污染的水或娱乐用水、免疫缺陷、囊性纤维化和口肛交。大约50%至75%的受感染儿童无症状。其他儿童表现为急性或慢性腹泻。检测完整生物体的直接荧光抗体试验,检测可溶性抗原的酶免疫测定,以及检测粪便样本中寄生虫特定基因的多重实时聚合酶链反应测定,与显微镜检查粪便标本以检测贾第鞭毛虫或囊肿相比,具有更高的灵敏度和特异性。本文综述了用于治疗症状性贾第虫病的药物。此外,最近的专利有关贾第虫病的管理也进行了讨论。结论:甲硝唑、替硝唑和硝唑尼特是首选药物。近年来,常见抗心绞痛药物的耐药性有所增加,因此迫切需要寻找新的抗心绞痛药物分子靶点。一般不建议对无症状携带者进行治疗。供水净化是一项重要的预防措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Giardiasis: An Overview.

Background: Giardiasis is an important cause of waterborne and foodborne diarrhea, daycare center outbreaks, and traveler's diarrhea.

Objective: The study aimed to provide an update on the evaluation, diagnosis, and treatment of giardiasis.

Methods: A PubMed search was completed in Clinical Queries using the key terms "giardiasis", "Giardia lamblia", "Giardia duodenalis" and "Giardia intestinalis". The search strategy included metaanalyses, randomized controlled trials, clinical trials, observational studies, and reviews. The search was restricted to the English literature. Patents were searched using the key term "giardiasis" from www.freepatentsonline.com.

Results: Giardiasis is caused by the protozoan parasite Giardia lamblia. The parasite is transmitted by the fecal-oral route, frequently through ingestion of contaminated water and food or person-to person transmission. Risk factors for infection include children in day-care settings, child-care workers, institutionalized individuals, travelers in endemic areas, ingestion of contaminated or recreational water, immunodeficiency, cystic fibrosis, and oral-anal sex. Approximately 50 to 75% of infected children are asymptomatic. Other children present acute or chronic diarrhea. Direct fluorescent antibody tests that detect intact organisms, enzyme immunoassays that detect soluble antigens, and multiplex real-time polymerase chain reaction assays that detect specific genes of the parasite in stool samples have improved sensitivity and specificity compared with microscopic examination of stool specimens for the detection of Giardia trophozoites or cysts. Drugs used in the treatment of symptomatic giardiasis are reviewed in this study. Moreover, recent patents related to the management of giardiasis are also discussed.

Conclusion: Metronidazole, tinidazole, and nitazoxanide are drugs of choice. Resistance to common antigiardial drugs has increased in recent years, therefore, the search for new molecular targets for antigiardial drugs is urgently needed. In general, treatment of asymptomatic carriers is not recommended. Purification of water supply is an important preventive measure.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
0
期刊介绍: Recent Patents on Inflammation & Allergy Drug Discovery publishes review articles by experts on recent patents in the field of inflammation and allergy drug discovery e.g. on novel bioactive compounds, analogs and targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信